1153 related articles for article (PubMed ID: 30951251)
21. Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis.
Yu R; Liu X; Deng X; Li S; Wang Y; Zhang Y; Ke D; Yan R; Wang Q; Tian X; Li M; Zeng X; Hu C
Front Immunol; 2023; 14():1211790. PubMed ID: 37662936
[TBL] [Abstract][Full Text] [Related]
22. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y; Wang W; Yu Y; Hu S
Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
[TBL] [Abstract][Full Text] [Related]
23. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.
Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR
Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891
[No Abstract] [Full Text] [Related]
24. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
[TBL] [Abstract][Full Text] [Related]
25. Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
Wan J; Yu Z; Cao X; Zhao X; Zhou W; Zheng Y
Clin Rheumatol; 2024 Jun; 43(6):1855-1863. PubMed ID: 38704780
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
Chen N; Diao CY; Gao J; Zhao DB
Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
[TBL] [Abstract][Full Text] [Related]
27. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
[TBL] [Abstract][Full Text] [Related]
28. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
[TBL] [Abstract][Full Text] [Related]
29. Management issues in rheumatoid arthritis-associated interstitial lung disease.
England BR; Hershberger D
Curr Opin Rheumatol; 2020 May; 32(3):255-263. PubMed ID: 32141954
[TBL] [Abstract][Full Text] [Related]
30. Assessment of interstitial lung disease among black rheumatoid arthritis patients.
McFarlane IM; Zhaz SY; Bhamra MS; Burza A; Kolla S; Alvarez MR; Koci K; Taklalsingh N; Pathiparampil J; Freeman L; Kaplan I; Kabani N; Ozeri DJ; Watler E; Frefer M; Vaitkus V; Matthew K; Arroyo-Mercado F; Lyo H; Zrodlowski T; Feoktistov A; Sanchez R; Sorrento C; Soliman F; Valdez FR; Dronamraju V; Trevisonno M; Grant C; Clerger G; Amin K; Dawkins M; Green J; Moon J; Fahmy S; Waite SA
Clin Rheumatol; 2019 Dec; 38(12):3413-3424. PubMed ID: 31471819
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
[TBL] [Abstract][Full Text] [Related]
32. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
[TBL] [Abstract][Full Text] [Related]
33. Assessment of risk factors in patients with rheumatoid arthritis-associated interstitial lung disease.
Severo CR; Chomiski C; Valle MBD; Escuissato DL; Paiva EDS; Storrer KM
J Bras Pneumol; 2022; 48(6):e20220145. PubMed ID: 36477171
[TBL] [Abstract][Full Text] [Related]
34. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
[TBL] [Abstract][Full Text] [Related]
35. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.
Kim Y; Yang HI; Kim KS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833957
[TBL] [Abstract][Full Text] [Related]
36. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.
Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F
Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866
[TBL] [Abstract][Full Text] [Related]
37. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
Bongartz T; Nannini C; Medina-Velasquez YF; Achenbach SJ; Crowson CS; Ryu JH; Vassallo R; Gabriel SE; Matteson EL
Arthritis Rheum; 2010 Jun; 62(6):1583-91. PubMed ID: 20155830
[TBL] [Abstract][Full Text] [Related]
38. Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Baker JF; England BR; George M; Cannon G; Sauer B; Ogdie A; Hamilton BC; Hunter C; Duryee MJ; Thiele G; Mikuls TR
Ann Rheum Dis; 2021 May; 80(5):566-572. PubMed ID: 33397733
[TBL] [Abstract][Full Text] [Related]
39. Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand - A retrospective cohort study.
Farquhar HJ; Beckert L; Edwards AL; Matteson EL; Frampton CMA; Ganly E; Yetton R; Thiessen R; Haslett J; Bucknall D; Stamp LK
Semin Arthritis Rheum; 2024 Feb; 64():152359. PubMed ID: 38157761
[TBL] [Abstract][Full Text] [Related]
40. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
